CAS NO: | 84746-43-0 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | Small Cardioactive Peptide B (SCPB), a neurally active peptide, stimulatesadenylate cyclaseactivity in particulate fractions of both heart and gill tissues withEC50s of 0.1 and 1.0 μM, respectively. | ||||||||||||||||
IC50& Target | EC50: 0.1 μM (adenylate cyclase, in heart tissues), 1.0 μM (adenylate cyclase, in gill tissues)[1] | ||||||||||||||||
体外研究 (In Vitro) | Small cardioactive peptide B (SCPB) is a neurally active peptide endogenous toAplysia. Small cardioactive peptide B (SCPB) possesses cardioexcitatory effects inAplysiaand reported a threshold concentration of 0.01 nM for both native and synthetic Small cardioactive peptide B (SCPB) stimulated effects on the isolated heart. Effects of Small Cardioactive Peptide B (SCPB) on the physiology of the isolated heart and gill preparations from the mollusc Aplysia californica were examined. In addition, the effects of Small Cardioactive Peptide B (SCPB) and FMRFamide (Phe-Met-Arg-Phe-NH2) on adenylate cyclase activity are compared in particulate fractions of heart and gill tissues, respectively. Small Cardioactive Peptide B (SCPB) is found to exert dose-dependent, reversible changes in cardiac activity when perfused through the isolated heart. The EC50values effecting changes in heart rate and force of contraction are 0.03 and 0.3 nM, respectively; minimum concentrations find to effect changes in heart rate and force of contraction are normally 0.001 and 1 pM, respectively. When perfused through the isolated gill, Small Cardioactive Peptide B (SCPB) is found to suppress the gill withdrawal response amplitude with a threshold concentration of 0.01 pM and an EC50value of 0.03 nM. Suppression of the gill withdrawal response amplitude by Small Cardioactive Peptide B (SCPB)is found to be dose dependent and reversible up to a concentration of 1nM. At higher concentrations, the suppression tended to persist irreversibly. Small Cardioactive Peptide B (SCPB) stimulates adenylate cyclase activity in particulate fractions of both heart and gill tissues with an EC50of 0.1 and 1.0μM, respectively[1]. | ||||||||||||||||
分子量 | 1141.41 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C52H80N14O11S2 | ||||||||||||||||
CAS 号 | 84746-43-0 | ||||||||||||||||
Sequence | Met-Asn-Tyr-Leu-Ala-Phe-Pro-Arg-Met-NH2 | ||||||||||||||||
Sequence Shortening | MNYLAFPRM-NH2 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Sealed storage, away from moisture and light, under nitrogen
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) | ||||||||||||||||
溶解性数据 | In Vitro: H2O : 50 mg/mL(43.81 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |